Should you invest in GlaxoSmithKline (LSE:GSK)? Our people
Science can improve health and well-being in so many ways, from the development of everyday healthcare products to medicines and vaccines. We are strengthening our R&D pipeline through a focus on immunology, human genetics and advanced technologies to help us identify transformational new medicines for patients.We are the world’s largest vaccines company by revenue, delivering vaccines that protect people at all stages of life. Governance
Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs
Responsibility reports & data
Total; 2020-08-13: 2020-10-08: H1 dividend (interim) 19: GBX: 2020-05-14: 2020-07-09: Q1 dividend: 19: GBX: 2020-02-20 : 2020-04-09: H2 dividend (final) 23: GBX: 80: 2019-11-14: 2020-01-09: Q3 dividend: 19: GBX: 2019-08-08: 2019-10-10: H1 dividend (interim) 19: GBX: 2019-05-16: 2019-07-11: Q1 dividend: 19: GBX: 2019 … Consumer Healthcare Joint Venture
Apprentices, students and graduates
We are a global company delivering billions of healthcare products a year.
Responsibility reports & data
Mr Olowookere can be reached via dipo.olowookere@businesspost.ng
We offer a broad range of employee benefits, including preventative healthcare services, so that we are able to attract and retain the best people.
GlaxoSmithKline Dividend Yield History.
By Dipo Olowookere The board of GlaxoSmithKline (GSK) Nigeria Plc has proposed the payment of 55 kobo dividend to shareholders for the 2019 financial year.
Postgraduate opportunities
Speeches & presentations
Analyst consensus
Our consumer healthcare products
COVID-19. Established dividend payer and good value. Operating responsibly
By delivering on …
our science and technology to address health needs, make our products affordable and available and to be a modern employer.GlaxoSmithKline plc. We offer a broad range of employee benefits, including preventative healthcare services, so that we are able to attract and retain the best people.
Media contact details
GSK @GSK. Stock exchange announcements
Trials in people
Our purpose is to help people to do more, feel better, live longer. Responsible business is how we do business. Comic Relief partnership
Last updated: 07 Sep 2020. Consumer Healthcare research
Information and tools for investors including share and dividend information, share price analysis, latest news and corporate reporting
Powered By: Business Post Integrated | Copyright 2020
Financial calendar
Corporate reporting
Friday 11 September, 2020
Discover our latest financial performance announcement and search for historical quarterly results materials
In Pharmaceuticals and Vaccines we focus on science related to the immune system, human genetics and advanced technology.
In Consumer Healthcare we leverage our scientific expertise and deep consumer insights to create healthcare products that meet consumer demands.Our ability to launch new products successfully and grow sales from our existing portfolio is key to our commercial success. In 2019, we finalised an agreement with Pfizer to combine our two consumer healthcare businesses.Our long-term priorities are designed to create lasting value for patients, consumers and shareholders and are underpinned by our ambition to build a culture with a greater performance focus, aligned to our values and expectations.